0      0

AONN+ 2020 Midyear Virtual Conference


SAT05 - General Session 4 | Mechanisms of Action – Integrating Biosimilars in Cancer Treatment


May 16, 2020 10:30am ‐ May 16, 2020 11:30am

Standard: $15.00

Description

This session will discuss biosimilars, their mechanism of action, and how to incorporate their use in patient treatments. Focus will be drawn on cost benefits and challenges encountered related to approval of biosimilars and how creation of more biosimilars will affect the pharmaceutical landscape.

Upon completion of the session, participants will be able to:

  • Define what is considered a biosimilar
  • Discuss biosimilars’ mechanism of action
  • Increase awareness on when incorporating biosimilars into treatments plans is beneficial
  • Discuss the process of obtaining coverage and funding/coverage for biosimilars

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content